Upgrades:
Phillips 66 (NYSE:PSX) was upgraded by investment analysts
at Bank of America from a “neutral” rating to a “buy” rating in a research
report issued on Monday, MarketBeat.com reports. The brokerage currently has a
$120.00 price target on the oil and gas company’s stock. Bank of America‘s
price target would indicate a potential upside of 111.27% from the stock’s
current price.
PSX has been the topic of several other research reports.
Royal Bank of Canada upgraded shares of Phillips 66 from a “sector perform”
rating to an “outperform” rating and set a $67.00 target price on the stock in
a research note on Sunday, March 29th. Piper Sandler dropped their target price
on shares of Phillips 66 from $139.00 to $120.00 and set an “overweight” rating
on the stock in a research note on Friday, February 28th. Barclays reiterated a
“buy” rating and issued a $94.00 target price on shares of Phillips 66 in a
research note on Wednesday, April 8th. Raymond James dropped their target price
on shares of Phillips 66 from $110.00 to $69.00 and set an “outperform” rating
on the stock in a research note on Tuesday, March 24th. They noted that the move
was a valuation call. Finally, Morgan Stanley upgraded shares of Phillips 66
from an “equal weight” rating to an “overweight” rating and set a $68.00 price
objective on the stock in a research report on Monday, March 16th. Two equities
research analysts have rated the stock with a sell rating and sixteen have
assigned a buy rating to the stock. Phillips 66 presently has an average rating
of “Buy” and a consensus price target of $86.93. Read more …
Goldman Sachs Group upgraded shares of Williams Companies
(NYSE:WMB) from a neutral rating to a buy rating in a research report report
published on Monday morning, BenzingaRatingsTable reports. They currently have
$23.00 target price on the pipeline company’s stock, up from their previous
target price of $19.00.
Several other equities analysts have also issued reports on
the stock. Wolfe Research raised shares of Williams Companies from a market
perform rating to an outperform rating in a report on Thursday, April 2nd.
Morgan Stanley reduced their target price on shares of Williams Companies from
$25.00 to $14.00 and set an equal weight rating for the company in a research
note on Monday, March 16th. Barclays raised shares of Williams Companies from
an equal weight rating to an overweight rating and set a $16.00 target price
for the company in a research note on Tuesday, March 24th. Wells Fargo & Co
reduced their target price on shares of Williams Companies from $20.00 to
$19.00 and set an equal weight rating for the company in a research note on Tuesday,
April 14th. Finally, Sanford C. Bernstein raised shares of Williams Companies
from a market perform rating to an outperform rating and reduced their target
price for the stock from $25.00 to $21.00 in a research note on Thursday, March
12th. Seven investment analysts have rated the stock with a hold rating, twelve
have given a buy rating and one has given a strong buy rating to the company’s
stock. Williams Companies currently has an average rating of Buy and an average
target price of $24.80. Read more …
Southwest Airlines (NYSE:LUV) was upgraded by research analysts at Susquehanna Bancshares from a “neutral” rating to a “positive” rating in a report issued on Tuesday, Briefing.com Automated Import reports. The brokerage currently has a $41.00 price objective on the airline’s stock. Susquehanna Bancshares’ price objective would indicate a potential upside of 32.00% from the company’s current price.
Southwest Airlines (NYSE:LUV) was upgraded by research analysts at Susquehanna Bancshares from a “neutral” rating to a “positive” rating in a report issued on Tuesday, Briefing.com Automated Import reports. The brokerage currently has a $41.00 price objective on the airline’s stock. Susquehanna Bancshares’ price objective would indicate a potential upside of 32.00% from the company’s current price.
LUV has been the topic of a number of other research
reports. JPMorgan Chase & Co. raised shares of Southwest Airlines from an
“underweight” rating to a “neutral” rating and decreased their price target for
the company from $49.00 to $36.00 in a research note on Monday, April 6th.
Cowen dropped their target price on Southwest Airlines from $45.00 to $40.00
and set an “outperform” rating for the company in a report on Monday. Raymond
James upgraded Southwest Airlines from a “market perform” rating to a
“strong-buy” rating and set a $50.00 price target on the stock in a report on
Monday, March 23rd. Zacks Investment Research lowered shares of Southwest
Airlines from a “hold” rating to a “sell” rating and set a $58.00 target price
for the company. in a report on Friday, January 3rd. Finally, Bank of America
raised Southwest Airlines from a “neutral” rating to a “buy” rating and cut
their price objective for the company from $48.00 to $43.00 in a research
report on Monday, March 23rd. Three equities research analysts have rated the
stock with a sell rating, ten have issued a hold rating, nine have assigned a
buy rating and one has issued a strong buy rating to the company. The stock
currently has an average rating of “Hold” and an average target price of
$52.55. Read more …
Bank of America upgraded shares of Johnson & Johnson
(NYSE:JNJ) from a neutral rating to a buy rating in a research note released on
Wednesday morning, Benzinga reports. The brokerage currently has $175.00 price
target on the stock, up from their previous price target of $150.00.
Other research analysts have also recently issued research
reports about the company. Cantor Fitzgerald reaffirmed a buy rating and set a
$168.00 target price on shares of Johnson & Johnson in a research note on
Friday, April 3rd. SVB Leerink decreased their target price on Johnson &
Johnson from $172.00 to $160.00 and set an outperform rating for the company in
a research note on Wednesday, April 8th. Argus reaffirmed a buy rating and set
a $155.00 target price (down previously from $165.00) on shares of Johnson
& Johnson in a research note on Friday, March 27th. Stifel Nicolaus upped
their target price on Johnson & Johnson from $140.00 to $155.00 and gave
the company a hold rating in a report on Wednesday, April 15th. Finally, Credit
Suisse Group upped their target price on Johnson & Johnson from $155.00 to
$161.00 and gave the company an outperform rating in a report on Wednesday,
April 15th. Three investment analysts have rated the stock with a hold rating
and thirteen have assigned a buy rating to the company’s stock. The company
presently has an average rating of Buy and a consensus price target of $162.36.
Read more …
Downgrades:
Walt Disney (NYSE:DIS) had its target price dropped by
investment analysts at Citigroup from $161.00 to $135.00 in a research report
issued on Tuesday, BenzingaRatingsTable reports. The firm presently has a “buy”
rating on the entertainment giant’s stock. Citigroup‘s price objective suggests
a potential upside of 35.54% from the company’s current price.
DIS has been the subject of a number of other reports.
Rosenblatt Securities reissued a “buy” rating and set a $140.00 target price on
shares of Walt Disney in a research note on Thursday, April 9th. SunTrust Banks
increased their price target on shares of Walt Disney from $110.00 to $160.00
and gave the company a “hold” rating in a research report on Tuesday, April
14th. Credit Suisse Group cut Walt Disney from an “outperform” rating to a
“neutral” rating and set a $116.00 price target for the company. in a research
note on Monday. Cowen raised their price target on shares of Walt Disney from
$154.00 to $159.00 and gave the stock an “outperform” rating in a report on
Wednesday, February 5th. Finally, UBS Group downgraded shares of Walt Disney
from a “buy” rating to a “neutral” rating and cut their price target for the
stock from $162.00 to $114.00 in a report on Monday. Eleven research analysts
have rated the stock with a hold rating and sixteen have issued a buy rating to
the stock. The stock currently has an average rating of “Buy” and a consensus
price target of $134.79. Read more …
BMO Capital Markets downgraded shares of Gilead Sciences
(NASDAQ:GILD) from an outperform rating to a market perform rating in a
research report report published on Monday, Benzinga reports. They currently
have $79.00 target price on the biopharmaceutical company’s stock.
Other equities analysts have also recently issued research
reports about the company. Bank of America lifted their price target on Gilead
Sciences from $70.00 to $72.00 and gave the stock a neutral rating in a
research note on Wednesday, February 5th. SVB Leerink reiterated a hold rating
and set a $68.00 price target on shares of Gilead Sciences in a report on
Monday, March 30th. Wolfe Research assumed coverage on Gilead Sciences in a
report on Tuesday, March 31st. They set a market perform rating and a $65.00
price target for the company. Cowen reiterated a buy rating and set a $80.00
price target on shares of Gilead Sciences in a report on Monday, April 13th.
Finally, Guggenheim lowered Gilead Sciences from a buy rating to a neutral
rating in a report on Tuesday, January 21st. Four research analysts have rated
the stock with a sell rating, sixteen have given a hold rating and twelve have
given a buy rating to the company. The company currently has an average rating
of Hold and a consensus target price of $76.81. Read more …
ONEOK (NYSE:OKE) was downgraded by Goldman Sachs Group from
a “buy” rating to a “neutral” rating in a report issued on Monday, The Fly
reports.
A number of other analysts have also recently issued reports
on the company. ValuEngine cut ONEOK from a “hold” rating to a “sell” rating in
a report on Tuesday, March 17th. Wells Fargo & Co increased their price
objective on ONEOK from $81.00 to $83.00 and gave the stock an “overweight”
rating in a research note on Wednesday, February 26th. Credit Suisse Group
raised ONEOK from a “neutral” rating to an “outperform” rating and reduced
their price objective for the stock from $79.00 to $50.00 in a research note on
Wednesday, March 11th. Morgan Stanley began coverage on ONEOK in a research
report on Monday, January 6th. They issued an “underweight” rating and a $63.00
target price on the stock. Finally, UBS Group lowered their price objective on
ONEOK from $42.00 to $38.00 and set a “buy” rating on the stock in a report on
Monday. Two equities research analysts have rated the stock with a sell rating,
nine have given a hold rating and eleven have assigned a buy rating to the stock.
The stock has an average rating of “Hold” and a consensus target price of
$67.00. Read more …
American Airlines Group (NASDAQ:AAL) was downgraded by
equities researchers at Susquehanna Bancshares from a “positive” rating to a
“neutral” rating in a note issued to investors on Tuesday, MarketBeat Ratings
reports. They currently have a $10.00 price objective on the airline’s stock.
Susquehanna Bancshares’ price objective would suggest a potential downside of
2.63% from the company’s previous close.
Several other equities research analysts also recently
weighed in on AAL. Evercore ISI downgraded American Airlines Group from an
“in-line” rating to an “underperform” rating in a report on Wednesday, March
11th. Wolfe Research downgraded American Airlines Group from a “market perform”
rating to an “underperform” rating in a report on Friday, March 27th. Bank of
America reduced their price target on American Airlines Group from $18.00 to
$5.00 and set an “underperform” rating on the stock in a report on Monday,
March 23rd. JPMorgan Chase & Co. downgraded American Airlines Group from an
“overweight” rating to an “underweight” rating in a report on Monday, April
6th. Finally, Citigroup reduced their price target on American Airlines Group
from $14.00 to $13.00 and set a “sell” rating on the stock in a report on
Monday, March 30th. Nine analysts have rated the stock with a sell rating,
eleven have issued a hold rating and four have given a buy rating to the
company. The company has an average rating of “Hold” and a consensus target
price of $20.56. Read more …
Gordon Haskett cut shares of Home Depot (NYSE:HD) from an
accumulate rating to a hold rating in a research report released on Wednesday
morning, 24/7 WallStreet reports.
HD has been the topic of several other reports. Morgan
Stanley cut their price objective on shares of Home Depot from $225.00 to
$215.00 and set an overweight rating on the stock in a report on Thursday,
April 2nd. Telsey Advisory Group boosted their price target on shares of Home
Depot from $230.00 to $244.00 and gave the stock a market perform rating in a
report on Wednesday, February 26th. Robert W. Baird reaffirmed a buy rating and
issued a $260.00 price objective (up from $245.00) on shares of Home Depot in a
research report on Tuesday, February 25th. Raymond James reissued a buy rating
and set a $270.00 target price on shares of Home Depot in a research report on
Thursday, March 5th. Finally, Credit Suisse Group reduced their target price on
Home Depot from $255.00 to $215.00 and set an outperform rating for the company
in a report on Wednesday, April 1st. One research analyst has rated the stock
with a sell rating, eleven have issued a hold rating, nineteen have issued a
buy rating and one has assigned a strong buy rating to the stock. The company
has a consensus rating of Buy and an average price target of $239.24. Read more…
Visa (NYSE:V) was downgraded by research analysts at
Guggenheim from a “buy” rating to a “neutral” rating in a research report
issued to clients and investors on Wednesday, The Fly reports.
A number of other research firms also recently weighed in on
V. Barclays dropped their target price on Visa from $230.00 to $209.00 and set
an “overweight” rating for the company in a report on Thursday, March 26th.
Robert W. Baird lifted their target price on Visa from $166.00 to $175.00 and
gave the stock an “outperform” rating in a report on Tuesday, March 31st.
Stephens dropped their price target on Visa from $228.00 to $192.00 and set an
“overweight” rating for the company in a research note on Wednesday, April 1st.
Macquarie started coverage on Visa in a research note on Tuesday, January 21st.
They issued an “outperform” rating and a $250.00 price target for the company.
Finally, Jefferies Financial Group downgraded Visa from a “buy” rating to a
“hold” rating and dropped their price target for the company from $190.00 to
$180.00 in a research note on Wednesday, April 15th. Five investment analysts
have rated the stock with a hold rating and twenty-four have issued a buy
rating to the stock. The company currently has a consensus rating of “Buy” and
a consensus price target of $202.67. Read more …
Diageo (NYSE:DEO) was downgraded by equities researchers at
Jefferies Financial Group from a “hold” rating to an “underperform” rating in a
report released on Friday, The Fly reports.
Other research analysts have also recently issued reports
about the company. Argus cut Diageo from a “buy” rating to a “hold” rating in a
research report on Tuesday, February 4th. Cfra lifted their target price on
Diageo from $166.00 to $175.00 and gave the company a “hold” rating in a
research note on Wednesday, February 5th. Investec downgraded Diageo from a
“hold” rating to a “sell” rating in a research note on Tuesday, March 17th.
Morgan Stanley downgraded Diageo from an “overweight” rating to an “equal
weight” rating in a research note on Monday. Finally, Edward Jones cut Diageo
from a “buy” rating to a “hold” rating in a report on Thursday. Five research
analysts have rated the stock with a sell rating, seven have assigned a hold
rating and two have issued a buy rating to the company’s stock. The stock
currently has a consensus rating of “Hold” and an average price target of
$145.00. Read more …
AT&T (NYSE:T) was downgraded by analysts at DZ Bank from
a “hold” rating to a “sell” rating in a note issued to investors on Friday,
Briefing.com Automated Import reports. They currently have a $26.00 price
target on the technology company’s stock. DZ Bank’s price target indicates a
potential downside of 11.86% from the stock’s previous close.
A number of other equities analysts have also commented on
the stock. JPMorgan Chase & Co. lowered shares of AT&T from an
“overweight” rating to a “neutral” rating and cut their price objective for the
stock from $38.00 to $35.00 in a report on Wednesday, April 1st. Tigress
Financial reiterated a “buy” rating on shares of AT&T in a report on
Friday, January 3rd. Credit Suisse Group cut their price objective on shares of
AT&T from $36.00 to $33.00 and set a “neutral” rating on the stock in a
report on Monday, April 13th. Morgan Stanley cut their price objective on
shares of AT&T from $42.00 to $38.00 and set an “overweight” rating on the
stock in a report on Friday, April 17th. Finally, Nomura Securities cut their
price objective on shares of AT&T from $44.00 to $39.00 and set a “buy”
rating on the stock in a report on Monday, March 30th. Three equities research
analysts have rated the stock with a sell rating, fourteen have issued a hold
rating and eleven have issued a buy rating to the stock. The company has a
consensus rating of “Hold” and a consensus price target of $36.40. Read more …
Omega Healthcare Investors Inc (NYSE:OHI) gapped down before
the market opened on Friday after Bank of America downgraded the stock from a
neutral rating to an underperform rating. The stock had previously closed at
$29.28, but opened at $28.14. Bank of America now has a $23.00 price target on
the stock, down from their previous price target of $25.00. Omega Healthcare
Investors shares last traded at $26.82, with a volume of 3,175,100 shares.
Other analysts have also recently issued research reports
about the stock. Citigroup cut their target price on shares of Omega Healthcare
Investors from $44.00 to $25.00 and set a “neutral” rating for the company in a
research note on Tuesday, April 7th. SunTrust Banks dropped their price
objective on shares of Omega Healthcare Investors from $36.00 to $32.00 and set
a “hold” rating for the company in a research note on Thursday. Zacks
Investment Research upgraded shares of Omega Healthcare Investors from a “sell”
rating to a “hold” rating in a research note on Thursday. Wells Fargo & Co
dropped their price objective on shares of Omega Healthcare Investors from
$43.00 to $28.00 and set an “equal weight” rating for the company in a research
note on Thursday, March 26th. Finally, Raymond James upgraded shares of Omega
Healthcare Investors from a “market perform” rating to an “outperform” rating
and set a $30.00 price objective for the company in a research note on
Wednesday, March 25th. Two equities research analysts have rated the stock with
a sell rating, four have assigned a hold rating and four have issued a buy
rating to the company’s stock. The company has an average rating of “Hold” and
an average target price of $34.89. Read more …
Hershey (NYSE:HSY) was downgraded by analysts at Piper
Sandler from an “overweight” rating to a “neutral” rating in a research note
issued on Friday, The Fly reports. They currently have a $138.00 price target
on the stock. Piper Sandler’s price target points to a potential upside of
0.80% from the company’s previous close.
Several other research analysts have also recently issued
reports on the company. Credit Suisse Group raised Hershey from a “neutral”
rating to an “outperform” rating and set a $160.00 price objective on the stock
in a research note on Wednesday, March 18th. Morgan Stanley began coverage on
Hershey in a research note on Tuesday. They issued an “equal weight” rating and
a $146.00 price objective on the stock. Royal Bank of Canada reissued a “hold”
rating and issued a $133.00 price objective on shares of Hershey in a research
note on Wednesday. Zacks Investment Research raised Hershey from a “sell”
rating to a “hold” rating and set a $154.00 target price on the stock in a
research report on Friday, December 27th. Finally, Evercore ISI reaffirmed a
“hold” rating and set a $150.00 target price on shares of Hershey in a research
report on Friday, January 31st. Two investment analysts have rated the stock
with a sell rating, seventeen have assigned a hold rating and three have issued
a buy rating to the company. The company presently has a consensus rating of
“Hold” and an average price target of $145.05. Read more …
Comments
Post a Comment